|
|
Article: Study Favors Drug-Eluting Stents Over Bare-Metal Stents in Key Patient Outcomes.
- Article from:
- PR Newswire
- Article date:
- February 5, 2007
CopyrightCOPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DES patients have significantly lower rates of death, heart attack and re-intervention than BMS patients
NATICK, Mass., Feb. 5 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today welcomed data from a study showing that drug- eluting stents (DES) have substantially lower rates of death, heart attack and re-intervention in real-world patients compared to bare-metal stents (BMS). The results of the study, "Comparison of Drug-Eluting Versus Bare-Metal Stents on Later Frequency of Acute Myocardial Infarction and Death," was published in the February 1 issue of the American Journal of Cardiology.
The observational study, which was conducted by the ...